Bestim: historical stereochemistry conflict — RU2120298C1
О.А. Кауров, С.А. Кетлинский, А.А. Колобов, А.С. Симбирцев · 1998 · RU2120298C1 · patent family 20174019
Published 1998-10-20.
Reported patent results
Narrative findings; numerical extraction incomplete
The patent reports restoration of lymphocyte measures in a selected case, with no controlled clinical effect estimate.
Historical Bestim patent describes gamma-L-Glu-L-Trp and selected immunodeficiency cases, including a patient after thymus removal.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Post-thymectomy case | Total and T-lymphocyte measures described as returning to normal; patient discharged in satisfactory condition | Single 18-year-old patient; image-based numerical table not transcribed |
| Other selected case | Colon-cancer-associated immunodeficiency example described | No verified group response rate or independently extracted effect size |
This L/L patent molecule differs from the D/L sequence on the current Bestim research card. Name similarity cannot transfer the clinical observation to a different stereoisomer.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Identity unresolved. This historical patent calls its agent Bestim but claim 1 specifies gamma-L-Glu-L-Trp. The current research card describes gamma-D-Glu-L-Trp.
These stereoisomers cannot be treated as identical. The name alone does not establish continuity between the patent, later literature and current products.
- Publication
- RU2120298C1 ↗ · 1998-10-20
- Earliest priority / filing
- 1995-11-28 / 1995-11-28
- Original applicant / assignee
- Товарищество с ограниченной ответственностью "Верта"; Товарищество с ограниченной ответственностью "Цитокин"
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 20174019 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Immunostimulating agent and a preparation based on thereof
Inventors: О.А. Кауров; С.А. Кетлинский; А.А. Колобов; А.С. Симбирцев.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- These stereoisomers cannot be treated as identical. The name alone does not establish continuity between the patent, later literature and current products.
- This L/L patent molecule differs from the D/L sequence on the current Bestim research card. Name similarity cannot transfer the clinical observation to a different stereoisomer.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-20174019. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: О.А. Кауров, С.А. Кетлинский, А.А. Колобов, А.С. Симбирцев. Bestim: historical stereochemistry conflict — RU2120298C1 RU2120298C1 · patent family 20174019 1998.
Molekul research summary: https://molekul.io/research/patent-ru2120298c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry